Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Cash And Cash Equivalents At Carrying Value of $231.25 million for the year ending 2025.
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +227.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $2.59 million | Q3 2014: $4.18 million | Q1 2015: $44.99 million | Q2 2015: $112.41 million | Q3 2015: $105.46 million | Q1 2016: $134.73 million | Q2 2016: $110.75 million | Q3 2016: $91.03 million | Q1 2017: $129.56 million | Q2 2017: $111.21 million | Q3 2017: $107.61 million | Q1 2018: $128.25 million | Q2 2018: $133.75 million | Q3 2018: $139.79 million | Q1 2019: $134.91 million | Q2 2019: $148.71 million | Q3 2019: $153.84 million | Q1 2020: $116.18 million | Q2 2020: $145.68 million | Q3 2020: $165.42 million | Q1 2021: $182.79 million | Q2 2021: $202.77 million | Q3 2021: $193.24 million | Q1 2022: $106.70 million | Q2 2022: $122.72 million | Q3 2022: $134.13 million | Q1 2023: $269.48 million | Q2 2023: $283.75 million | Q3 2023: $258.53 million | Q1 2024: $228.61 million | Q2 2024: $172.89 million | Q3 2024: $38.96 million | Q1 2025: $96.19 million | Q2 2025: $117.35 million | Q3 2025: $150.10 million.
- Over the full 14 years of available data (2012 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Cash And Cash Equivalents At Carrying Value has grown by 1,837.4%.
- Historical annual values: Fiscal year 2025: $231.25 million | Fiscal year 2024: $70.57 million | Fiscal year 2023: $238.95 million | Fiscal year 2022: $173.69 million | Fiscal year 2021: $186.43 million | Fiscal year 2020: $174.12 million | Fiscal year 2019: $170.02 million | Fiscal year 2018: $146.63 million | Fiscal year 2017: $118.70 million | Fiscal year 2016: $153.23 million | Fiscal year 2015: $95.70 million | Fiscal year 2014: $1.63 million | Fiscal year 2013: $7.55 million | Fiscal year 2012: $11.94 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: